This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Torres-Roca, J. F. Articles by Yeatman, T. Search for Related Content PubMed PubMed Citation Articles by Torres-Roca, J. F. Articles by Yeatman, T.

Prediction of Radiation Sensitivity Using a Gene Expression Classifier

Departments of ¹ Interdisciplinary Oncology and ² Surgery, University of South Florida College of Medicine and H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida

Requests for reprints: Javier F. Torres-Roca, Department of Interdisciplinary Oncology, University of South Florida College of Medicine and H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, MOD-9, Tampa, FL 33612. Phone: 813-972-8424; Fax: 813-979-7231; E-mail: torresjf{at}moffitt.usf.edu.

The development of a successful radiation sensitivity predictive assay has been a major goal of radiation biology for several decades. We have developed a radiation classifier that predicts the inherent radiosensitivity of tumor cell lines as measured by survival fraction at 2 Gy (SF2), based on gene expression profiles obtained from the literature. Our classifier correctly predicts the SF2 value in 22 of 35 cell lines from the National Cancer Institute panel of 60, a result significantly different from chance (P = 0.0002). In our approach, we treat radiation sensitivity as a continuous variable, significance analysis of microarrays is used for gene selection, and a multivariate linear regression model is used for radiosensitivity prediction. The gene selection step identified three novel genes (RbAp48, RGS19, and R5PIA) of which expression values are correlated with radiation sensitivity. Gene expression was confirmed by quantitative real-time PCR. To biologically validate our classifier, we transfected RbAp48 into three cancer cell lines (HS-578T, MALME-3M, and MDA-MB-231). RbAp48 overexpression induced radiosensitization (1.5- to 2-fold) when compared with mock-transfected cell lines. Furthermore, we show that HS-578T-RbAp48 overexpressors have a higher proportion of cells in G₂-M (27% versus 5%), the radiosensitive phase of the cell cycle. Finally, RbAp48 overexpression is correlated with dephosphorylation of Akt, suggesting that RbAp48 may be exerting its effect by antagonizing the Ras pathway. The implications of our findings are significant. We establish that radiation sensitivity can be predicted based on gene expression profiles and we introduce a genomic approach to the identification of novel molecular markers of radiation sensitivity.

This article has been cited by other articles:

				S. A. Amundson, K. T. Do, L. C. Vinikoor, R. A. Lee, C. A. Koch-Paiz, J. Ahn, M. Reimers, Y. Chen, D. A. Scudiero, J. N. Weinstein, et al. Integrating Global Gene Expression and Radiation Survival Parameters across the 60 Cell Lines of the National Cancer Institute Anticancer Drug Screen Cancer Res., January 15, 2008; 68(2): 415 - 424. [Abstract] [Full Text] [PDF]

				A. Scuto, H. Zhang, H. Zhao, M. Rivera, T. J. Yeatman, R. Jove, and J. F. Torres-Roca RbAp48 Regulates Cytoskeletal Organization and Morphology by Increasing K-Ras Activity and Signaling through Mitogen-Activated Protein Kinase Cancer Res., November 1, 2007; 67(21): 10317 - 10324. [Abstract] [Full Text] [PDF]

				L. Kong, X.-P. Yu, X.-H. Bai, W.-F. Zhang, Y. Zhang, W.-M. Zhao, J.-H. Jia, W. Tang, Y.-B. Zhou, and C.-j. Liu RbAp48 Is a Critical Mediator Controlling the Transforming Activity of Human Papillomavirus Type 16 in Cervical Cancer J. Biol. Chem., September 7, 2007; 282(36): 26381 - 26391. [Abstract] [Full Text] [PDF]

				M.-H. Tsai, J. A. Cook, G. V.R. Chandramouli, W. DeGraff, H. Yan, S. Zhao, C. N. Coleman, J. B. Mitchell, and E. Y. Chuang Gene Expression Profiling of Breast, Prostate, and Glioma Cells following Single versus Fractionated Doses of Radiation Cancer Res., April 15, 2007; 67(8): 3845 - 3852. [Abstract] [Full Text] [PDF]